Clinical Trials

A Phase 1b Study of LY2835219 in Combination with Multiple Single-Agent Options for Patients with Stage IV NSCLC


Study ID
Eli Lilly I3Y-MC-JPBJ

NCT Number
NCT02079636 (Click on the NCT number for more information about the trial)

Research Study Number
00004654

Principle Investigator
Dr. Martin Gutierrez

Phase
I

Sponsor
Eli Lilly


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now